Skip to main content

Table 1 Overview of the results

From: Recovery from (treatment-resistant) depression after lifestyle changes and micronutrient precision supplementation: a preliminary field study in patients

Case no

m/f

vit. start 1 = deficient

vit. end

DHEA-S start

DHEA-S end

DASS-21 start

DASS-21 end

DASS-21 diff

suppl. start 1 = yes 0 = no

wrong suppl. start 1 = yes

diagnosis at start

depr. duration

depr. at start 1 = yes 0 = no

Status end (free text)

existing antidepr. med

additional info/ background/trigger

1

F

1

0

1

1

28

4

-24

1

1

depression

6 mon

1

very good

0

 

2

F

0

0

0

0

52

60

 + 8

1

 

depression

6 mon

1

unchanged

0

trauma

3

F

0

0

0

0

20

58

 + 38

1

   

0

life incident

0

 

4

F

0

0

0

0

22

28

 + 6

1

   

0

stress increased

0

Hashimoto

5

F

1

0

0

0

68

36

-32

1

1

depression

4 mon

1

good

1

injury

6

F

1

0

0

0

48

40

-8

0

 

depression

5 + yrs

1

better

1

SSRI

7

F

0

0

0

0

32

28

-4

1

 

depression

5 + yrs

1

much better

0

Hashimoto

8

F

0

0

0

0

2

2

0

1

   

0

unchanged

0

 

9

F

1

0

0

0

74

14

-60

0

 

depression

2 mon

1

very good

0

 

10

F

1

0

1

0

64

28

-36

1

1

depression

6 mon

1

much better

0

Hashimoto

11

M

0

0

0

0

52

22

-30

1

   

0

better

0

 

12

F

1

0

0

0

86

28

-58

0

 

depression

2–5 yrs

1

good

1

SSRI

13

M

0

0

0

0

8

6

-2

1

   

0

very good

0

 

14

F

1

0

0

0

50

12

-38

1

1

depression

5 + yrs

1

good

0

 

15

M

1

0

0

0

32

0

-32

1

1

depr.episodes

6 mon

1

very good

0

 

16

M

1

0

0

0

44

8

-36

0

 

depr.episodes

2–5 yrs

1

good

0

 

17

F

0

0

0

0

8

2

-6

1

   

0

very good

0

 
  1. abbr.: m male, f female, vit vitamins B9/B12/C/D, DASS-21 Depression-Anxiety-Stress-Scales with 21 items, suppl. supplementation, diagnosis at start = diagnosed (by treating physician), antidepr. antidepressant, add. additional, OCD obsessive compulsive disorder, SSRI selective serotonin reuptake inhibitor